Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios

Back

ESC Premium Access

Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios

Session: Progress in stroke prevention in atrial fibrillation

Topic: Atrial fibrillation (AF)

Speaker: Doctor A. Nissen Bonde (Gentofte, DK)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Anders Nissen Bonde

Gentofte University Hospital, Gentofte (Denmark)

0 follower

6 more presentations in this session

Adherence to anticoagulant drugs in patients with atrial fibrillation and stroke in real clinical practice

Speaker: Professor D. Duplyakov (Samara, RU)

Access

Abstract

Slides

Periprocedural anticoagulation is associated with the risk of thromboembolism after elective cardioversion of atrial fibrillation.

Speaker: Doctor T. Hellman (Turku, FI)

Access

Abstract

Slides

Reduced fibrin clot permeability is associated with an increased risk of both ischemic stroke and major bleeding in atrial fibrillation patients treated with vitamin k antagonists

Speaker: Professor A. Undas (Krakow, PL)

Access

Abstract

Slides

The impact of age on the effectiveness and safety of the NOACs versus warfarin for stroke prevention in atrial fibrillation

Speaker: Doctor P. Noseworthy (Rochester, US)

Access

Abstract

Slides

Use of novel oral anticoagulants in patients with atrial fibrillation and moderate to severe renal dysfunction: findings from a prospective national registry

Speaker: Professor I. Goldenberg (Rochester, US)

Access

Abstract

Slides

Access the full session

Progress in stroke prevention in atrial fibrillation

Speakers: Doctor A. Nissen Bonde, Professor D. Duplyakov, Doctor T. Hellman, Professor A. Undas, Doctor P. Noseworthy...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources